Jane Street’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21.2M | Buy |
138,600
+104,500
| +306% | +$16M | ﹤0.01% | 1736 |
|
|
2025
Q4 | $4.7M | Buy |
34,100
+15,400
| +82% | +$2.02M | ﹤0.01% | 3327 |
|
|
2025
Q3 | $2.4M | Buy |
18,700
+4,600
| +33% | +$561K | ﹤0.01% | 4606 |
|
|
2025
Q2 | $1.71M | Buy |
14,100
+6,800
| +93% | +$766K | ﹤0.01% | 4686 |
|
|
2025
Q1 | $814K | Sell |
7,300
-3,100
| -30% | -$330K | ﹤0.01% | 5962 |
|
|
2024
Q4 | $1.01M | Buy |
10,400
+8,600
| +478% | +$917K | ﹤0.01% | 5368 |
|
|
2024
Q3 | $207K | Buy |
+1,800
| New | +$204K | ﹤0.01% | 8599 |
|
|
2023
Q1 | – | Sell |
-10,300
| Closed | -$934K | – | 9654 |
|
|
2022
Q4 | $934K | Buy |
10,300
+7,600
| +281% | +$640K | ﹤0.01% | 5091 |
|
|
2022
Q3 | $205K | Sell |
2,700
-8,900
| -77% | -$738K | ﹤0.01% | 8142 |
|
|
2022
Q2 | $981K | Sell |
11,600
-4,400
| -28% | -$386K | ﹤0.01% | 5515 |
|
|
2022
Q1 | $1.4M | Sell |
16,000
-24,500
| -60% | -$2.12M | ﹤0.01% | 5424 |
|
|
2021
Q4 | $3.54M | Sell |
40,500
-16,900
| -29% | -$1.4M | ﹤0.01% | 3408 |
|
|
2021
Q3 | $4.69M | Buy |
57,400
+6,200
| +12% | +$558K | ﹤0.01% | 2845 |
|
|
2021
Q2 | $4.67M | Sell |
51,200
-33,100
| -39% | -$2.95M | ﹤0.01% | 2759 |
|
|
2021
Q1 | $7.21M | Sell |
84,300
-24,100
| -22% | -$2.16M | ﹤0.01% | 1923 |
|
|
2020
Q4 | $10.2M | Buy |
108,400
+22,800
| +27% | +$1.99M | 0.01% | 1394 |
|
|
2020
Q3 | $7.44M | Buy |
85,600
+16,300
| +24% | +$1.41M | ﹤0.01% | 1464 |
|
|
2020
Q2 | $6.05M | Buy |
69,300
+22,900
| +49% | +$1.98M | ﹤0.01% | 1638 |
|
|
2020
Q1 | $3.83M | Buy |
46,400
+33,900
| +271% | +$3.02M | ﹤0.01% | 1391 |
|
|
2019
Q4 | $1.18M | Sell |
12,500
-14,300
| -53% | -$1.28M | ﹤0.01% | 2545 |
|
|
2019
Q3 | $2.33M | Buy |
26,800
+16,400
| +158% | +$1.47M | ﹤0.01% | 1640 |
|
|
2019
Q2 | $950K | Buy |
+10,400
| New | +$880K | ﹤0.01% | 2764 |
|
|
2019
Q1 | – | Sell |
-15,847
| Closed | -$1.22M | – | 5428 |
|
|
2018
Q4 | $1.22M | Sell |
15,847
-8,147
| -34% | -$634K | ﹤0.01% | 2296 |
|
|
2018
Q3 | $1.85M | Buy |
+23,994
| New | +$1.77M | ﹤0.01% | 2001 |
|
|
2018
Q2 | – | Sell |
-18,079
| Closed | -$1.31M | – | 5411 |
|
|
2018
Q1 | $1.31M | Buy |
+18,079
| New | +$1.38M | ﹤0.01% | 2333 |
|
|
2017
Q4 | – | Sell |
-6,250
| Closed | -$481K | – | 5000 |
|
|
2017
Q3 | $481K | Sell |
6,250
-1,674
| -21% | -$126K | ﹤0.01% | 3141 |
|
|
2017
Q2 | $593K | Buy |
7,924
+112
| +1% | +$7.94K | ﹤0.01% | 2812 |
|
|
2017
Q1 | $520K | Sell |
7,812
-1,228
| -14% | -$81.8K | ﹤0.01% | 2829 |
|
|
2016
Q4 | $590K | Buy |
+9,040
| New | +$586K | ﹤0.01% | 2668 |
|
|
2016
Q1 | – | Sell |
-7,924
| Closed | -$611K | – | 4486 |
|
|
2015
Q4 | $611K | Buy |
+7,924
| New | +$629K | ﹤0.01% | 2265 |
|
|
2013
Q4 | – | Sell |
-5,245
| Closed | -$361K | – | 2724 |
|
|
2013
Q3 | $361K | Sell |
5,245
-49,885
| -90% | -$3.3M | ﹤0.01% | 1946 |
|
|
2013
Q2 | $3.49M | Buy |
+55,130
| New | +$3.59M | 0.06% | 254 |
|
Other funds holding NVS
Jane Street's NVS Position: Q1 2026 in Review
Jane Street opened a new position in Novartis (NVS) in Q1 2026: 366,467 shares worth $56M. The stake represents 0.01% of the portfolio and ranks #979 among its holdings. This is a return to the name: Jane Street previously reported a position in NVS as recently as Q3 2025.
Jane Street first reported a position in NVS in Q2 2013 and has held it in 48 quarters since. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Jane Street held 366,467 shares of Novartis worth $56M as of Q1 2026.
- Novartis was a new Jane Street position in Q1 2026.
- Novartis made up 0.01% of Jane Street's portfolio in Q1 2026, its #979 holding.
- Jane Street first reported a position in Novartis in Q2 2013 and has held it in 48 quarters since.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.